Purchase Order 36C24425P0281

Award Date 2/3/25
Potential Completion Date 6/3/25
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $19,238.26 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization specializing in the supply of radiopharmaceuticals. The contract, which is not set aside, provides a 3-month "bridge" procurement of radiopharmaceuticals to support nuclear medicine imaging procedures across the VA's Veterans Integrated Service Network (VISN) 4, which covers facilities in the northeastern...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit company specializing in the supply of radiopharmaceuticals for the VA healthcare system. The $111,392.95 delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $4,038,178.15 with the VA's Veterans Integrated Service Network (VISN) 2 for general radiopharmaceuticals, with a performance period through February 2026. The contract does not...
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price purchase order contract to Nuclear Diagnostic Products, Inc., a for-profit organization headquartered in Rockaway, New Jersey. The contract, valued at $91,658.40, is for the supply of GA-68 NETSPOT, a radiopharmaceutical product used in nuclear medicine diagnostic procedures, to support the VA's healthcare services for veterans. This contract is not a set-aside award. Nuclear Diagnostic Products, Inc. is an established...
This is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization specializing in the supply of radiopharmaceuticals. The contract, valued at $174,071.55, is for the delivery of general radiopharmaceuticals to support nuclear medicine imaging procedures across the VA's Veterans Integrated Service Network (VISN) 2, which covers facilities in the northeastern United States. This contract is part of a larger Indefinite...
This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization specializing in the supply of radiopharmaceuticals. The contract, valued at $330,602.10, is for the provision of general radiopharmaceuticals to support nuclear medicine imaging procedures across the VA's Veterans Integrated Service Network (VISN) 2, which covers facilities primarily in the northeastern United States. The...
This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Nuclear Diagnostic Products, Inc., a for-profit organization, on May 2, 2018. The $107,176.03 contract is for the provision of radiopharmaceuticals to support nuclear medicine imaging procedures for veterans at VA facilities in VISN 4, which covers Pennsylvania and Delaware. Nuclear Diagnostic Products, Inc. is an established prime vendor of radiopharmaceuticals to the...
This is a federal delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization specializing in radiopharmaceutical supplies. The contract, valued at $215,958.40, is for the provision of general radiopharmaceuticals to support nuclear medicine imaging procedures within the VA's Veterans Integrated Service Network (VISN) 2, which covers facilities in the northeastern United States. The contract is a firm fixed-price...
This federal contract award, valued at $103,865.20, was issued by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc. for the provision of general radiopharmaceuticals to support the Veterans Integrated Service Network (VISN) 2 healthcare system. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the company, which provides specialized radiopharmaceutical products to VA medical centers in the northeastern United States....
The Department of Veterans Affairs (VA) has awarded a firm fixed price delivery order contract to Nuclear Diagnostic Products, Inc., a for-profit organization, to provide general radiopharmaceuticals for the VA's Veterans Integrated Service Network (VISN) 2, which covers facilities in New York and New Jersey. This $610,950.85 contract has a completion date of February 21, 2024. Nuclear Diagnostic Products, Inc. is the prime contractor and has been awarded numerous similar contracts by the VA...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $113,291.46 firm-fixed-price purchase order contract to Nuclear Diagnostic Products, Inc., a for-profit organization, to provide the radiopharmaceutical NETSPOT (GA-68 DOTATATE). This contract supports nuclear medicine services at multiple VA medical centers in New York, New Jersey, and Delaware, and has a period of performance through January 8, 2024. The contract was awarded on January 9, 2023 and was not set...

This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization specializing in the supply of radiopharmaceuticals. The contract, valued at $34,371.90, is for the delivery of BRIDGE NETSPOT GA68, a radiopharmaceutical product used in nuclear medicine imaging procedures.

The contract is not set aside for any specific business type. Nuclear Diagnostic Products, Inc. has been awarded numerous prime contracts with the VA, primarily supporting diagnostic imaging services across Veterans Integrated Service Networks (VISNs) 2 and 4, which cover facilities in the northeastern United States. The company holds several Indefinite Delivery Contracts (IDVs) with the VA, valued at over $4 million each, to provide general radiopharmaceuticals and specialized products like ILLUCCIX (Gallium 68 PSMA-11) to VA medical centers. This contract award demonstrates the company's consistent ability to deliver critical radiopharmaceutical products that support veteran healthcare diagnostics.

Generated 2/4/25, 10:39 AM